RxDoctor Payments Data

Ernesto Garcia Santiago, MD

Internal Medicine · Caguas, PRNPI 1609820414

Payments from drug & device makers

$2,642in general payments, 2019–2025

Across 53 payments — averaging $49.85 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$1K
  • E.r. Squibb & Sons, L.L.C.$307
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$274
  • AbbVie$172
  • GE HealthCare$150
  • Lilly USA, LLC$149
  • plus $438 from 8 others

What the payments were for

  • Consulting fees$69026%
  • Food & beverage$1,95274%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,642 in reported general payments places this provider in the 80th percentile of 1,043 internal medicine providers in Puerto Rico.

See all internal medicine providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$18,614
Medicare patients
49
Services billed
162

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban160$123,626
XareltoRivaroxaban66$67,108
TrulicityDulaglutide42$47,460
JardianceEmpagliflozin35$39,500
FarxigaDapagliflozin Propanediol33$34,234
JanuviaSitagliptin Phosphate36$33,310
SynthroidLevothyroxine Sodium384$31,999
TradjentaLinagliptin30$31,779
JanumetSitagliptin Phos/Metformin Hcl31$26,436
SynjardyEmpagliflozin/Metformin Hcl29$20,967
Trijardy XrEmpaglifloz/Linaglip/Metformin17$19,429
KeppraLevetiracetam26$18,592
Janumet XrSitagliptin Phos/Metformin Hcl24$18,457
Sucralfate250$17,017
BrilintaTicagrelor27$16,077

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Tradjenta, Synjardy, Trijardy Xr, Synjardy Xr$42$119,865124 claims
MerckJanuvia, Janumet, Janumet Xr$54$78,20291 claims
Johnson & JohnsonXarelto$1,152$67,10866 claims
Lilly USA, LLCTrulicity, Humalog, Humulin N$149$56,508139 claims
AstraZenecaFarxiga, Brilinta, Symbicort$106$55,50283 claims
AbbVieSynthroid$172$31,999384 claims
Sanofi-aventis U.S. LLCLantus$20$14,348136 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 1,043 internal medicine providers in Puerto Rico.

Other internal medicine in Caguas

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →